immunological studies have shown an increased lymphocyte reactivity in patients with early stage bladder cancer and individuals with pre-stage t1 exposed to bladder carcinogens ( 2-naphthylamine and industrial 1-naphthylamine containing 4-8 % 2-naphthylamine ) before 1952-that is , those at high risk of developing bladder cancer .
C0005682
bladder
C0005684
bladder cancer